Patent · US Active

Method of treating deviated nasal septum, enlarged nasal turbinate, or mucosal hypertrophy

US11696775B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Acclarent, Inc. · US

Inventors

Jetmir Palushi · Irvine, US
Fatemeh Akbarian · Rancho Palos Verdes, US
Athanasios Papadakis · Newport Beach, US
Ehsan Shameli · Irvine, US
William J. Kane · Newport Beach, US
Henry F. Salazar · Pico Rivera, US
Julie M. Taylor · Yorba Linda, US
Marc Dean · Fort Worth, US

Key dates

Filing date	Apr 29, 2019
Grant date	Jul 11, 2023
Priority date	—
Expiry date	Aug 6, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2210/0618
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method includes inserting a first dilation catheter into a first nostril of a patient. A first dilator of the first dilation catheter is positioned between the nasal septum of the patient and the turbinate of the patient. The first dilator is expanded, thereby remodeling one or more of the nasal septum, the turbinate, or mucosal tissue of the patient. The first dilation catheter is removed from the nostril of the patient. A second dilation catheter may be inserted into a second nostril of the patient. A dilator of the second dilation catheter may provide an opposing force on the nasal septum to prevent over-medialization of the nasal septum.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.